Siegfried Holding AG
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pa… Read more
Siegfried Holding AG (SGFEF) - Net Assets
Latest net assets as of December 2024: $979.91 Million USD
Based on the latest financial reports, Siegfried Holding AG (SGFEF) has net assets worth $979.91 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.93 Billion) and total liabilities ($953.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $979.91 Million |
| % of Total Assets | 50.67% |
| Annual Growth Rate | 9.46% |
| 5-Year Change | 33.65% |
| 10-Year Change | 111.61% |
| Growth Volatility | 11.84 |
Siegfried Holding AG - Net Assets Trend (2013–2024)
This chart illustrates how Siegfried Holding AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Siegfried Holding AG (2013–2024)
The table below shows the annual net assets of Siegfried Holding AG from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $979.91 Million | +16.92% |
| 2023-12-31 | $838.13 Million | +5.97% |
| 2022-12-31 | $790.93 Million | +14.92% |
| 2021-12-31 | $688.22 Million | -6.13% |
| 2020-12-31 | $733.18 Million | +8.02% |
| 2018-12-31 | $678.78 Million | +1.65% |
| 2017-12-31 | $667.79 Million | +1.07% |
| 2016-12-31 | $660.74 Million | +34.12% |
| 2015-12-31 | $492.65 Million | +6.39% |
| 2014-12-31 | $463.06 Million | +27.77% |
| 2013-12-31 | $362.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Siegfried Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 110.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $836.92 Million | 85.38% |
| Other Components | $143.28 Million | 14.62% |
| Total Equity | $980.19 Million | 100.00% |
Siegfried Holding AG Competitors by Market Cap
The table below lists competitors of Siegfried Holding AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CD Projekt S.A
PINK:OTGLF
|
$4.05 Billion |
|
Laurus Labs Limited
NSE:LAURUSLABS
|
$4.06 Billion |
|
INPOST S.A. EO -01
F:669
|
$4.06 Billion |
|
Trex Company Inc
NYSE:TREX
|
$4.06 Billion |
|
GUNMA BK LTD
F:5F0
|
$4.05 Billion |
|
SKYLARK
F:SKX
|
$4.05 Billion |
|
Inpost SA
AS:INPST
|
$4.05 Billion |
|
Huizhou Desay SV Automotive Co Ltd Class A
SHE:002920
|
$4.05 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Siegfried Holding AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 838,237,000 to 980,192,000, a change of 141,955,000 (16.9%).
- Net income of 160,064,000 contributed positively to equity growth.
- Dividend payments of 15,386,000 reduced retained earnings.
- Share repurchases of 18,746,000 reduced equity.
- New share issuances of 967,000 increased equity.
- Other factors increased equity by 15,056,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $160.06 Million | +16.33% |
| Dividends Paid | $15.39 Million | -1.57% |
| Share Repurchases | $18.75 Million | -1.91% |
| Share Issuances | $967.00K | +0.1% |
| Other Changes | $15.06 Million | +1.54% |
| Total Change | $- | 16.93% |
Book Value vs Market Value Analysis
This analysis compares Siegfried Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.57x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 5.85x to 4.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $175.34 | $1025.00 | x |
| 2021-12-31 | $163.45 | $1025.00 | x |
| 2022-12-31 | $187.80 | $1025.00 | x |
| 2023-12-31 | $197.49 | $1025.00 | x |
| 2024-12-31 | $224.46 | $1025.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Siegfried Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.33%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.36%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 1.97x
- Recent ROE (16.33%) is above the historical average (11.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 14.86% | 14.36% | 0.70x | 1.48x | $17.61 Million |
| 2014 | 10.07% | 12.23% | 0.50x | 1.64x | $337.77K |
| 2015 | 7.94% | 8.14% | 0.48x | 2.04x | $-10.17 Million |
| 2016 | 4.22% | 3.89% | 0.70x | 1.55x | $-38.17 Million |
| 2017 | 6.11% | 5.44% | 0.70x | 1.60x | $-25.96 Million |
| 2018 | 8.30% | 7.09% | 0.72x | 1.63x | $-11.57 Million |
| 2020 | 8.30% | 7.20% | 0.68x | 1.69x | $-12.45 Million |
| 2021 | 13.89% | 8.67% | 0.66x | 2.43x | $26.78 Million |
| 2022 | 19.79% | 12.73% | 0.69x | 2.27x | $77.40 Million |
| 2023 | 13.45% | 8.87% | 0.68x | 2.22x | $28.95 Million |
| 2024 | 16.33% | 12.36% | 0.67x | 1.97x | $62.04 Million |
Industry Comparison
This section compares Siegfried Holding AG's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Siegfried Holding AG (SGFEF) | $979.91 Million | 14.86% | 0.97x | $4.05 Billion |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |